文献速递关节外科

口服奈福泮对全膝关节置换术后多模式镇痛疗效的前瞻性双盲安慰剂对照随机试验

Efficacy of Oral Nefopam on Multimodal Analgesia in Total Knee Arthroplasty: A Prospective, Double-Blind, Placebo-Controlled, Randomized Trial.
PubMed 文献 · J Arthroplasty · 2024-02-23

这项前瞻性双盲安慰剂对照随机试验纳入100例全膝关节置换术患者,比较在多模式镇痛(塞来昔布200mg、普瑞巴林150mg每日两次)基础上加用口服奈福泮40mg每日两次与安慰剂的疗效。结果显示奈福泮组术后24小时内及住院期间阿片类药物消耗量更低、静息和运动VAS评分更低、术后第1和2天功能恢复更好、住院时间更短,但绝对改善幅度未超过报告的最小临床重要差异,两组肝功能指标和并发症发生率相似。

要点

  • 奈福泮组术后24小时内及住院期间羟考酮与吗啡消耗量显著低于对照组。
  • 奈福泮组术后24小时内静息和运动VAS评分更低,术后第1、2天功能恢复更好,住院时间更短。
  • 阿片消耗量、VAS评分和膝关节活动度的绝对改善未超过报告的最小临床重要差异。

核心结论

  • 在多模式镇痛中加入口服奈福泮使阿片类药物消耗量、VAS疼痛评分和功能恢复获得统计学显著改善,但改善幅度可能无临床重要性。

研究设计与样本

  • 前瞻性、双盲、安慰剂对照随机试验,纳入在本院接受全膝关节置换术的100例患者,随机分为奈福泮组和对照组。
  • 奈福泮组术后接受塞来昔布200mg、普瑞巴林150mg和奈福泮40mg每日两次;对照组接受塞来昔布200mg、普瑞巴林150mg和安慰剂。
  • 盐酸羟考酮10mg用作补救镇痛药;若疼痛仍控制不佳,皮下注射盐酸吗啡10mg作为二级补救镇痛药。

主要发现

  • 奈福泮组术后24小时内及住院期间羟考酮与吗啡消耗量显著低于对照组。
  • 奈福泮组术后24小时内静息和运动VAS疼痛评分显著低于对照组。
  • 奈福泮组术后第1天和第2天功能恢复(膝关节活动度和步行距离)优于对照组,住院时间更短。
  • 0至24小时阿片消耗量、VAS疼痛评分和膝关节活动度的绝对降低未超过报告的最小临床重要差异。
  • 两组肝功能指标和并发症发生率相似。

局限性

  • 0至24小时阿片消耗量、VAS疼痛评分和膝关节活动度的绝对改善未超过报告的最小临床重要差异,改善幅度可能无临床重要性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multimodal analgesia is central to pain management after total knee arthroplasty (TKA). This study aimed to evaluate the efficacy of adding oral nefopam to multimodal analgesia for post-TKA pain management. METHODS: In this prospective, double-blind, placebo-controlled, randomized trial, 100 patients who underwent TKA at our hospital were randomized to either the nefopam or the control group. After surgery, patients in the nefopam group received 200 mg of celecoxib, 150 mg of pregabalin, and 40 mg of nefopam twice daily to control postoperative pain. Patients in the control group received 200 mg of celecoxib, 150 mg of pregabalin, and a placebo. Oxycodone hydrochloride (10 mg) was used as the rescue analgesic. If the pain remained poorly controlled, 10 mg of morphine hydrochloride was injected subcutaneously as a secondary rescue analgesic. The primary outcome was the postoperative consumption of oxycodone and morphine as rescue analgesics. Secondary outcomes were postoperative pain assessed using the visual analogue scale (VAS), functional recovery assessed by the range of knee motion and ambulation distance, time until hospital discharge, indicators of liver function, and complication rates. RESULTS: Patients in the nefopam group had significantly lower postoperative oxycodone and morphine consumption within 24 hours after surgery and during hospitalization, lower VAS pain scores at rest and during motion within 24 h after surgery, better functional recovery on postoperative days 1 and 2, and a shorter hospital stay. However, the absolute reduction in 0 to 24 h opioid consumption, VAS pain scores, and knee range of motion did not exceed the reported minimal clinically important difference. Both groups had similar indicators of liver function and complication rates. CONCLUSIONS: Adding oral nefopam to multimodal analgesia resulted in statistically significant improvements in opioid consumption, VAS pain scores, and functional recovery. However, the amount of improvement may not be clinically important.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Wang Q, Hu J, Ye S, et al. Efficacy of Oral Nefopam on Multimodal Analgesia in Total Knee Arthroplasty: A Prospective, Double-Blind, Placebo-Controlled, Randomized Trial. J Arthroplasty. 2024. PMID: 38403077. doi:10.1016/j.arth.2024.02.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。